TGFB1 and neoplasm: Many of the growth-factor-stimulated pathways are constitutively activated by paracrine or autocrine secretion of and response to growth factors (such as TGFβ) either in tumor cells or in the contributing cells in the tumor microenvironment (for example, stromal and hematopoietic cells) [55,56].